- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Hypertension Treatment Options in Patients with Obesity
Which hypertension treatment options should be used as first-line therapy in patients with obesity? A clinician's answer and explanation, here.
What evidence-based strategies and guidelines should clinicians consider when assessing and managing hypertension in patients with obesity?
Is a question Patient Care Online recently asked Jonathan Parker, DO, MS, president of the Alabama Obesity Society in an interview. "We do not have clear obesity-directed hypertension guidelines. We are still going by typical American College of Cardiology/American Heart Association guidelines in terms of treating hypertension," said Dr Parker.
In the video below, Dr Parker discusses common treatments for hypertension—including thiazide diuretics, beta blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors—and which one he recommends for first-line treatment in patients with obesity.
Dr Parker is also a family and obesity medicine physician at Avalon Medical Group in Muscle Shoals, Alabama.
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.
